Bausch Health
409 hedge funds and large institutions have $32.4B invested in Bausch Health in 2013 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 138 increasing their positions, 148 reducing their positions, and 32 closing their positions.
141% more first-time investments, than exits
New positions opened: 77 | Existing positions closed: 32
57% more call options, than puts
Call options by funds: $524M | Put options by funds: $335M
30% more funds holding in top 10
Funds holding in top 10: 46 → 60 (+14)
13% more capital invested
Capital invested by funds: $28.8B → $32.4B (+$3.62B)
11% more funds holding
Funds holding: 368 → 409 (+41)
0.12% less ownership
Funds ownership: 82.82% → 82.7% (-0.12%)
7% less repeat investments, than reductions
Existing positions increased: 138 | Existing positions reduced: 148
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$314M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
+$179M |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$94.3M |
| 4 |
VAM
Visium Asset Management
New York
|
+$84M |
| 5 |
BWCA
Brenner West Capital Advisors
New York
|
+$52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$459M |
| 2 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$101M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$79M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$70.2M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
-$68M |
BHC Hedge Fund Activity: Q4 2013 in Review
409 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q4 2013, worth a combined $32.4B — up 13% from $28.8B a quarter earlier.
Buyers outnumbered sellers: 77 funds opened new BHC positions and 32 closed out — a net gain of 45 holders — while 138 added to existing stakes and 148 trimmed.
The largest buyer was Barclays, adding an estimated $314M. The largest seller was Fidelity Investments, cutting an estimated $459M.
- 409 institutional investors held Bausch Health (BHC) as of Q4 2013, up from 368 in Q3 2013.
- Funds reported $32.4B of Bausch Health stock for Q4 2013, up 13% quarter-over-quarter.
- 77 funds opened new Bausch Health positions in Q4 2013 and 32 closed out, a net change of +45 holders.
- The largest Bausch Health buyer in Q4 2013 was Barclays, an estimated $314M added.
- The largest Bausch Health seller in Q4 2013 was Fidelity Investments, an estimated $459M sold.
Based on aggregated 13F filings for Q4 2013.